Jasper Therapeutics, Inc. (JSPR)
NASDAQ·Healthcare·Biotechnology
$0.92
-0.84%
Mkt Cap $21.29M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$41.67
Range $3.00 – $65.00
Implied Upside
+4419.0%
Consensus $41.67 vs current $0.92
NASDAQ·Healthcare·Biotechnology
$0.92
-0.84%
Mkt Cap $21.29M
No recent rating data.
Price Target (6 analysts)
$41.67
Range $3.00 – $65.00
+4419.0%
Consensus $41.67 vs current $0.92